Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Rocket Lab U Surges 3.1% Today - Is There Still Upside?

Shares of Rocket Lab U rose to $62.82 during today's afternoon trading session. Despite the 3.1% change, the Large-Cap Defense company still trades 7.08% above its average analyst target price of $58.67. So there may be further downside for the Defense stock. Rocket Lab U has target prices ranging from $45.0 to $83.0 per share, and its average rating is buy.

Rocket Lab U has an elevated short interest of 13.0%. The stock's short ratio, or the number of days needed for all shorts to cover their positions, is 1.96. The company's insiders own 1.98% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. 61.3% of Rocket Lab U shares are held by institutional investors, which indicates a high level of confidence in the stock.

Institutions Invested in Rocket Lab U

Date Reported Holder Percentage Shares Value
2025-06-30 Vanguard Group Inc 8% 39,682,158 $2,492,833,153
2025-06-30 Blackrock Inc. 5% 22,757,870 $1,429,649,386
2025-06-30 VK Services, LLC 4% 21,323,617 $1,339,549,613
2025-06-30 Bank of America Corporation 3% 13,503,364 $848,281,322
2025-06-30 Capital World Investors 3% 13,219,556 $830,452,503
2025-06-30 Shaw D.E. & Co., Inc. 2% 11,477,962 $721,045,569
2025-06-30 State Street Corporation 2% 10,912,334 $685,512,818
2025-06-30 Deer Management Co. LLC 2% 8,168,616 $513,152,454
2025-06-30 Geode Capital Management, LLC 1% 6,996,653 $439,529,739
2025-06-30 UBS Group AG 1% 6,673,480 $419,228,011

For these reasons, we consider that the Rocket Lab U is the subject of mixed market sentiment.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS